<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Neurosurgery Blog</title>
	<atom:link href="http://www.neurosurgery-blog.com/feed" rel="self" type="application/rss+xml" />
	<link>http://www.neurosurgery-blog.com</link>
	<description>Daily bibliographic review of the Neurosurgery Department Hospital General Universitario de Alicante, Spain</description>
	<lastBuildDate>Wed, 08 Sep 2010 04:00:00 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging</title>
		<link>http://www.neurosurgery-blog.com/archives/1500</link>
		<comments>http://www.neurosurgery-blog.com/archives/1500#comments</comments>
		<pubDate>Wed, 08 Sep 2010 04:00:00 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Functional]]></category>
		<category><![CDATA[Stereotactic neurosurgery]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[neurorradiology]]></category>
		<category><![CDATA[7-tesla magnetic resonance imaging]]></category>
		<category><![CDATA[Deep Brain Stimulation]]></category>
		<category><![CDATA[internal globus pallidus]]></category>
		<category><![CDATA[Parkinson disease]]></category>
		<category><![CDATA[Subthalamic nucleus]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1500</guid>
		<description><![CDATA[J Neurosurg 113:639–647, 2010.DOI: 10.3171/2010.3.JNS091385
A challenge associated with deep brain stimulation (DBS) in treating advanced Parkinson disease (PD) is the direct visualization of brain nuclei, which often involves indirect approximations of stereotactic targets. In the present study, the authors compared T2*-weighted images obtained using 7-T MR imaging with those obtained using 1.5- and 3-T MR [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/09/STN7t.jpg"><img class="alignleft size-full wp-image-1501" title="STN7t" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/09/STN7t.jpg" alt="" width="114" height="114" /></a>J Neurosurg 113:639–647, 2010.DOI: 10.3171/2010.3.JNS091385</strong></p>
<p style="text-align: justify;">A challenge associated with deep brain stimulation (DBS) in treating advanced Parkinson disease (PD) is the direct visualization of brain nuclei, which often involves indirect approximations of stereotactic targets. In the present study, the authors compared T2*-weighted images obtained using 7-T MR imaging with those obtained using 1.5- and 3-T MR imaging to ascertain whether 7-T imaging enables better visualization of targets for DBS in PD.</p>
<p style="text-align: justify;">Methods. The authors compared 1.5-, 3-, and 7-T MR images obtained in 11 healthy volunteers and 1 patient with PD.</p>
<p style="text-align: justify;">Results. With 7-T imaging, distinct images of the brain were obtained, including the subthalamic nucleus (STN) and internal globus pallidus (GPi). Compared with the 1.5- and 3-T MR images of the STN and GPi, the 7-T MR images showed marked improvements in spatial resolution, tissue contrast, and signal-to-noise ratio.</p>
<p style="text-align: justify;">Conclusions. Data in this study reveal the superiority of 7-T MR imaging for visualizing structures targeted for DBS in the management of PD. This finding suggests that by enabling the direct visualization of neural structures of interest, 7-T MR imaging could be a valuable aid in neurosurgical procedures.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1500/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comparison of percutaneous balloon compression and glycerol rhizotomy for the treatment of trigeminal neuralgia</title>
		<link>http://www.neurosurgery-blog.com/archives/1495</link>
		<comments>http://www.neurosurgery-blog.com/archives/1495#comments</comments>
		<pubDate>Tue, 07 Sep 2010 04:00:59 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Functional]]></category>
		<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Pain]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[balloon compression]]></category>
		<category><![CDATA[glycerol injection]]></category>
		<category><![CDATA[Trigeminal neuralgia]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1495</guid>
		<description><![CDATA[J Neurosurg 113:486–492, 2010.DOI: 10.3171/2010.1.JNS091106
The aim of this study was to compare percutaneous balloon compression (PBC) and percutaneous retrogasserian glycerol rhizotomy (PRGR) in terms of effectiveness, complications, and technical aspects.
Methods. Sixty-six consecutive PBC procedures were performed in 45 patients between January 2004 and December 2008, and 120 PRGR attempts were performed in 101 patients between [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/09/Glycerol-balloon.jpg"><img class="alignleft size-medium wp-image-1497" title="Glycerol-balloon" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/09/Glycerol-balloon-300x194.jpg" alt="" width="180" height="116" /></a>J Neurosurg 113:486–492, 2010.DOI: 10.3171/2010.1.JNS091106</strong></p>
<p style="text-align: justify;">The aim of this study was to compare percutaneous balloon compression (PBC) and percutaneous retrogasserian glycerol rhizotomy (PRGR) in terms of effectiveness, complications, and technical aspects.</p>
<p style="text-align: justify;">Methods. Sixty-six consecutive PBC procedures were performed in 45 patients between January 2004 and December 2008, and 120 PRGR attempts were performed in 101 patients between January 2006 and December 2008. The PRGR procedures were not completed due to technical reasons in 19 cases. Five patients in the Balloon Compression Group and 9 patients in the Glycerol Group were lost to follow-up and were excluded from the study. The medical records and the intraoperative fluoroscopic images from the remaining cases were retrospectively examined, and the follow-up was completed with telephone contact, when necessary. The 2 groups were compared in terms of initial effect, duration of effect, and rates of complications as well as severity and type of complications.</p>
<p style="text-align: justify;">Results. The rates for immediate pain relief were 87% for patients treated with glycerol injection and 85% for patients treated with balloon compression. The Kaplan-Meier plots for the 2 treatment modalities were similar. The 50% recurrence time was 21 months for the balloon procedure and 16 months for the glycerol procedure. When the groups were broken down by the “previous operations” criterion, the 50% recurrence time was 24 months for the Glycerol First Procedure Group, 6 months for the Balloon First Procedure Group, 8 months for the Glycerol Previous Procedures Group, and 21 months for the Balloon Previous Procedures Group. The rates of complications (excluding numbness) were 11% for PRGR and 23% for PBC, and this difference was statistically significant (chi-square test, p = 0.04).</p>
<p style="text-align: justify;">Conclusions. Both PRGR and PBC are effective techniques for the treatment of trigeminal neuralgia, with PRGR presenting some advantages in terms of milder and fewer complications and allowing lighter anesthesia without compromise of analgesia. For these reasons the authors consider PRGR as the first option for the treatment of trigeminal neuralgia in patients who are not suitable candidates or are not willing to undergo microvascular decompression, while PBC is reserved for patients in whom the effect of PRGR has proven to be short or difficult to repeat due to cisternal fibrosis.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1495/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gamma Knife Surgery for Cavernous Hemangiomas in the Cavernous Sinus</title>
		<link>http://www.neurosurgery-blog.com/archives/1490</link>
		<comments>http://www.neurosurgery-blog.com/archives/1490#comments</comments>
		<pubDate>Mon, 06 Sep 2010 04:00:31 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Vascular]]></category>
		<category><![CDATA[radiosurgery]]></category>
		<category><![CDATA[Cavernous hemangioma]]></category>
		<category><![CDATA[cavernous sinus]]></category>
		<category><![CDATA[gamma-knife]]></category>
		<category><![CDATA[Stereotactic radiosurgery]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1490</guid>
		<description><![CDATA[Neurosurgery 67:611-616, 2010 DOI: 10.1227/01.NEU.0000378026.23116.E6
Cavernous hemangioma in the cavernous sinus (CS) is a rare vascular tumor. Direct microsurgical approach usually results in massive hemorrhage. Radiosurgery has emerged as a treatment alternative to microsurgery.
OBJECTIVE: To further investigate the role of Gamma Knife surgery (GKS) in treating CS hemangiomas.
METHODS: This was a retrospective analysis of 7 patients [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/09/CSHemangioma1.jpg"><img class="alignleft size-full wp-image-1492" title="CSHemangioma1" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/09/CSHemangioma1.jpg" alt="" width="104" height="91" /></a>Neurosurgery 67:611-616, 2010 DOI: 10.1227/01.NEU.0000378026.23116.E6</strong></p>
<p style="text-align: justify;">Cavernous hemangioma in the cavernous sinus (CS) is a rare vascular tumor. Direct microsurgical approach usually results in massive hemorrhage. Radiosurgery has emerged as a treatment alternative to microsurgery.</p>
<p style="text-align: justify;">OBJECTIVE: To further investigate the role of Gamma Knife surgery (GKS) in treating CS hemangiomas.</p>
<p style="text-align: justify;">METHODS: This was a retrospective analysis of 7 patients with CS hemangiomas treated by GKS between 1993 and 2008. Data from 84 CS meningiomas treated during the same period were also analyzed for comparison. The patients underwent follow-up magnetic resonance imaging at 6-month intervals. Data on clinical and imaging changes after radiosurgery were analyzed.</p>
<p style="text-align: justify;">RESULTS: Six months after GKS, magnetic resonance imaging revealed an average of 72% tumor volume reduction (range, 56%-83%). After 1 year, tumor volume decreased 80% (range, 69%-90%) compared with the pre-GKS volume. Three patients had &gt; 5 years of follow- up, which showed the tumor volume further decreased by 90% of the original size. The average tumor volume reduction was 82%. In contrast, tumor volume reduction of the 84 cavernous sinus meningiomas after GKS was only 29% (P &lt; .001 by Mann-Whitney U test). Before treatment, 6 patients had various degrees of ophthalmoplegia. After GKS, 5 improved markedly within 6 months. Two patients who suffered from poor vision improved after radiosurgery.</p>
<p style="text-align: justify;">CONCLUSION: GKS is an effective and safe treatment modality for CS hemangiomas with long-term treatment effect. Considering the high risks involved in microsurgery, GKS may serve as the primary treatment choice for CS hemangiomas.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1490/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Postoperative Assessment of Clipped Aneurysms With 64-Slice Computerized Tomography Angiography</title>
		<link>http://www.neurosurgery-blog.com/archives/1483</link>
		<comments>http://www.neurosurgery-blog.com/archives/1483#comments</comments>
		<pubDate>Fri, 03 Sep 2010 04:00:28 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Vascular]]></category>
		<category><![CDATA[neurorradiology]]></category>
		<category><![CDATA[Aneurysm remnant]]></category>
		<category><![CDATA[Cerebral aneurysm]]></category>
		<category><![CDATA[Cerebrovascular surgery]]></category>
		<category><![CDATA[Clipping]]></category>
		<category><![CDATA[Multidetector computerized tomography angiography]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1483</guid>
		<description><![CDATA[Neurosurgery 67:844-854, 2010 DOI: 10.1227/01.NEU.0000374684.10920.A2
Multidetector computerized tomography angiography (MDCTA) is now a widely accepted technique for the management of intracranial aneurysms.
OBJECTIVE: To evaluate its accuracy for the postoperative assessment of clipped intracranial aneurysms.
METHODS:We analyzed a consecutive series of 31 patients that underwent direct surgical clipping procedures of 38 aneurysms. A 64 slice MDCT scanner (Aquilion [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/09/CTA-DSA.jpg"><img class="alignleft size-full wp-image-1488" title="CTA-DSA" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/09/CTA-DSA.jpg" alt="" width="98" height="98" /></a>Neurosurgery 67:844-854, 2010 DOI: 10.1227/01.NEU.0000374684.10920.A2</p>
<p style="text-align: justify;">Multidetector computerized tomography angiography (MDCTA) is now a widely accepted technique for the management of intracranial aneurysms.</p>
<p style="text-align: justify;">OBJECTIVE: To evaluate its accuracy for the postoperative assessment of clipped intracranial aneurysms.</p>
<p style="text-align: justify;">METHODS:We analyzed a consecutive series of 31 patients that underwent direct surgical clipping procedures of 38 aneurysms. A 64 slice MDCT scanner (Aquilion 64, Toshiba) was used and results were compared with digital subtraction angiographies (DSA). Two independent neuroradiologists analyzed the following data: examination quality, artifacts, aneurysm remnant, and patency of collateral branches. Interobserver agreement, sensitivity, and specificity were calculated.</p>
<p style="text-align: justify;">RESULTS: Seventy-nine percent of the aneurysms were located in the anterior circulation. Significant artifacts were found with multiple and cobalt-alloy clips. According to DSA, remnants &gt;2 mm were found in 21% of the cases, and 2 patients had one collateral branch occluded. Sensitivity and specificity of 64-MDCTA for the detection of aneurysm remnants were 50% and 100%, respectively. Sensitivity and specificity of 64-MDCTA for the detection of a significant remnant (&gt;2 mm) and the detection of the occlusion of a collateral branch were, respectively, 67% and 100% and 50% and 100%. No relationship was found with the location, type, shape, size, or number of clips, but missed remnants tended to be larger with cobalt-alloy clips.</p>
<p style="text-align: justify;">CONCLUSIONS: 64-MDCTA is a valuable technique to assess the presence of a significant postoperative remnant in single titanium clip application cases and might be useful for longterm follow-up. DSA remains the most accurate postoperative radiological examination.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1483/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Near-infrared indocyanine green videoangiography versus microvascular Doppler sonography in aneurysm surgery</title>
		<link>http://www.neurosurgery-blog.com/archives/1477</link>
		<comments>http://www.neurosurgery-blog.com/archives/1477#comments</comments>
		<pubDate>Thu, 02 Sep 2010 04:00:25 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Vascular]]></category>
		<category><![CDATA[Aneurysm clipping]]></category>
		<category><![CDATA[Digital substraction angiography]]></category>
		<category><![CDATA[Microvascular Doppler sonography]]></category>
		<category><![CDATA[Near infrared indocyanine green videoangiography]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1477</guid>
		<description><![CDATA[Acta Neurochir (2010) 152:1519–1525.DOI 10.1007/s00701-010-0723-5
The quality of surgical treatment of intracranial aneurysms is determined by complete aneurysm occlusion and restoration of flow in the parent, branching and perforating vessels. In postoperative digital subtraction angiography (DSA), unexpected aneurysm residuals and vessel occlusions are frequently detected. Here, the value of two nearly noninvasive and cost-effective techniques for [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/08/AICAAn.jpg"><img class="alignleft size-full wp-image-1478" title="AICAAn" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/08/AICAAn.jpg" alt="" width="106" height="102" /></a>Acta Neurochir (2010) 152:1519–1525.DOI 10.1007/s00701-010-0723-5</p>
<p style="text-align: justify;">The quality of surgical treatment of intracranial aneurysms is determined by complete aneurysm occlusion and restoration of flow in the parent, branching and perforating vessels. In postoperative digital subtraction angiography (DSA), unexpected aneurysm residuals and vessel occlusions are frequently detected. Here, the value of two nearly noninvasive and cost-effective techniques for intraoperative flow evaluation (near-infrared indocyanine green video angiography (ICG-VA) and microvascular Doppler sonography (mDs)) is investigated in a prospective study.</p>
<p style="text-align: justify;">Patients and methods Over a period of 10months, the authors surgically clipped 50 aneurysms under intraoperative pre- and post-clipping evaluation of flow in the parent, branching and perforating vessels and the aneurysm sack by the two techniques. Intraoperative applicability of each technique was compared to each other and to postoperative digital subtraction angiography as standard evaluation technique.</p>
<p style="text-align: justify;">Results Forty-five aneurysms were totally occluded without vessel compromise (90%). Intraoperatively, ICG-VA was considered useful in 43 cases (86%) and mDs in 44 cases (88%), respectively. Both techniques could compensate each other’s weak points to a certain degree; but two branch occlusions (4%) and three neck remnants (6%) were revealed by postoperative DSA.</p>
<p style="text-align: justify;">Conclusion Both techniques have specific drawbacks that could be compensated by each other, to a certain extent. Intraoperatively, ICG-VA and mDs should not be considered competitive, but complementary. This study implicates that the combination of both applications on a routine basis assures the quality of aneurysm surgery by nearly noninvasive and cost-effective techniques. However, DSA remains the gold standard for evaluation of aneurysm occlusion.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1477/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Endoscopic Treatment of Arachnoid Cysts: A Detailed Account of Surgical Techniques and Results</title>
		<link>http://www.neurosurgery-blog.com/archives/1473</link>
		<comments>http://www.neurosurgery-blog.com/archives/1473#comments</comments>
		<pubDate>Wed, 01 Sep 2010 04:00:33 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Developmental Malformations]]></category>
		<category><![CDATA[Endoscopy]]></category>
		<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Arachnoid cyst]]></category>
		<category><![CDATA[Cystocisternostomy]]></category>
		<category><![CDATA[Cystoventriculostomy]]></category>
		<category><![CDATA[Ventriculocystocisternostomy]]></category>
		<category><![CDATA[Ventriculocystostomy]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1473</guid>
		<description><![CDATA[Neurosurgery 67:824-836, 2010 DOI: 10.1227/01.NEU.0000377852.75544.E4
Surgical treatment of arachnoid cysts remains under debate. Although many authors favor endoscopic techniques, others attribute a higher recurrence rate to the endoscope.
OBJECTIVE: The authors report their experience with endoscopic procedures for arachnoid cyst.
METHODS: All pure endoscopic procedures for arachnoid cysts performed by the authors were analyzed. Particular reference was given [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/08/cystostomy.jpg"><img class="alignleft size-full wp-image-1474" title="cystostomy" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/08/cystostomy.jpg" alt="" width="90" height="84" /></a>Neurosurgery 67:824-836, 2010 DOI: 10.1227/01.NEU.0000377852.75544.E4</p>
<p style="text-align: justify;">Surgical treatment of arachnoid cysts remains under debate. Although many authors favor endoscopic techniques, others attribute a higher recurrence rate to the endoscope.</p>
<p style="text-align: justify;">OBJECTIVE: The authors report their experience with endoscopic procedures for arachnoid cyst.</p>
<p style="text-align: justify;">METHODS: All pure endoscopic procedures for arachnoid cysts performed by the authors were analyzed. Particular reference was given to surgical complications and patient outcome in relation to cyst location and endoscopic technique.</p>
<p style="text-align: justify;">RESULTS: Sixty-six endoscopic procedures were performed in 61 patients (mean age, 28 years; range, 23 days to 74 years; 35 males, 26 females). The main presenting symptoms were cephalgia (61%), hemisymptoms (18%), and macrocephalus (18%). Cyst location was temporobasal (34%), suprasellar (21%), at the cisterna quadrigemina (18%), paraxial supratentorial (16%), and various (10%). Thirty cystocisternostomies, 14 ventriculocystostomies, 12 cystoventriculostomies, and 10 ventriculocystocisternostomies were performed. The overall clinical success rate was 90%. The endoscopic technique was abandoned in 4 cases (7%). Postoperative complications were found in 16%; there was only one permanent deficit (2%). Five recurrences (8%) occurred up to 7 years after the first procedure. Of the various locations, the temporobasal cysts were the most difficult to treat with lowest clinical success (81%), highest recurrence (19%), and highest complication rate (24%). Of the various endoscopic techniques, ventriculocystostomy and ventriculocystocisternostomy reached the highest success rates with 100%.</p>
<p style="text-align: justify;">CONCLUSIONS: Endoscopic techniques provide very good results in arachnoid cyst treatment. The most frequent cyst location is the most difficult to treat. A long-term follow-up is recommended since recurrences can occur many years after the procedure</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1473/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Best surgical practices: a stepwise approach to the University of Pennsylvania deep brain stimulation protocol</title>
		<link>http://www.neurosurgery-blog.com/archives/1467</link>
		<comments>http://www.neurosurgery-blog.com/archives/1467#comments</comments>
		<pubDate>Tue, 31 Aug 2010 04:00:55 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Clinical Guide]]></category>
		<category><![CDATA[Functional]]></category>
		<category><![CDATA[Stereotactic neurosurgery]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Deep Brain Stimulation]]></category>
		<category><![CDATA[dystonia]]></category>
		<category><![CDATA[essential tremor]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1467</guid>
		<description><![CDATA[Neurosurg Focus 29 (2):E3, 2010. (DOI: 10.3171/2010.4.FOCUS10103)
Deep brain stimulation (DBS) is the treatment of choice for otherwise healthy patients with advanced Parkinson disease who are suffering from disabling dyskinesias and motor fluctuations related to dopaminergic therapy. As DBS is an elective procedure, it is essential to minimize the risk of morbidity. Further, precision in targeting [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/08/STXbestpractice.jpg"><img class="alignleft size-full wp-image-1468" title="STXbestpractice" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/08/STXbestpractice.jpg" alt="" width="136" height="132" /></a>Neurosurg Focus 29 (2):E3, 2010. (DOI: 10.3171/2010.4.FOCUS10103)</p>
<p style="text-align: justify;">Deep brain stimulation (DBS) is the treatment of choice for otherwise healthy patients with advanced Parkinson disease who are suffering from disabling dyskinesias and motor fluctuations related to dopaminergic therapy. As DBS is an elective procedure, it is essential to minimize the risk of morbidity. Further, precision in targeting deep brain structures is critical to optimize efficacy in controlling motor features. The authors have already established an operational checklist in an effort to minimize errors made during DBS surgery. Here, they set out to standardize a strict, step-by-step approach to the DBS surgery used at their institution, including preoperative evaluation, the day of surgery, and the postoperative course. They provide careful instruction on Leksell frame assembly and placement as well as the determination of indirect coordinates derived from MR images used to target deep brain structures. Detailed descriptions of the operative procedure are provided, outlining placement of the stereotactic arc as well as determination of the appropriate bur hole location, lead placement using electrophysiology, and placement of the internal pulse generator. The authors also include their approach to preventing postoperative morbidity. They believe that a strategic, step-by-step approach to DBS surgery combined with a standardized checklist will help to minimize operating room mistakes that can compromise targeting and increase the risk of complication.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1467/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Image-guided frameless stereotactic biopsy without intraoperative neuropathological examination. Clinical article</title>
		<link>http://www.neurosurgery-blog.com/archives/1459</link>
		<comments>http://www.neurosurgery-blog.com/archives/1459#comments</comments>
		<pubDate>Mon, 30 Aug 2010 04:00:12 +0000</pubDate>
		<dc:creator>javier</dc:creator>
				<category><![CDATA[Neuronavigation]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Stereotactic neurosurgery]]></category>
		<category><![CDATA[ambulatory day-case surgery]]></category>
		<category><![CDATA[brain tumor]]></category>
		<category><![CDATA[intraoperative neuropathological examination]]></category>
		<category><![CDATA[multiple specimens]]></category>
		<category><![CDATA[stereotactic biopsy]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1459</guid>
		<description><![CDATA[
Journal of Neurosurgery, August 2010 Volume 113, Number 2
DOI: 10.3171/2009.12.JNS09573
Stereotactic biopsy is a safe and effective technique for the diagnosis of brain tumors. The use of intraoperative neuropathological examination has been routinely advocated to increase diagnostic yield, but the procedure lengthens surgical time, may produce false-negative and -positive results, and current biopsy techniques have a [...]]]></description>
			<content:encoded><![CDATA[<div>
<div><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/08/Dibujo1.jpg"><img class="alignleft size-full wp-image-1463" title="Dibujo" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/08/Dibujo1.jpg" alt="" width="126" height="146" /></a>Journal of Neurosurgery, August 2010 Volume 113, Number 2</div>
<div>DOI: 10.3171/2009.12.JNS09573</div>
<div style="text-align: justify;">Stereotactic biopsy is a safe and effective technique for the diagnosis of brain tumors. The use of intraoperative neuropathological examination has been routinely advocated to increase diagnostic yield, but the procedure lengthens surgical time, may produce false-negative and -positive results, and current biopsy techniques have a very low nondiagnostic rate. Therefore, the authors questioned the need for intraoperative histological evaluation.</div>
<div style="text-align: justify;">Methods</div>
<div style="text-align: justify;">The authors prospectively studied all patients undergoing image-guided biopsy under the care of a single surgeon (P.L.G.) between July 2005 and October 2007. A Stryker neuronavigation system with a trajectory guide was used to plan a single trajectory, and, using a side-cutting biopsy cannula, multiple biopsy samples were taken from between 1 and 4 sites within the tumor. Tissue was inspected macroscopically by the surgeon and was only submitted for neuropathological assessment postoperatively.</div>
<div style="text-align: justify;">Results</div>
<div style="text-align: justify;">One hundred thirty-four biopsies were performed during the study. A positive diagnosis was established in 133 cases (99.3%). One biopsy was negative (0.7%) and postoperative imaging (performed because the tissue was macroscopically normal) demonstrated inaccurate targeting of the lesion. Significant complications were seen in 3 patients (2.2%) who all had preoperative WHO performance scores of III or IV. Two patients suffered delayed deterioration and died due to probable surgical complications—one with thalamic glioblastoma multiforme (GBM) and one with gliomatosis cerebri. One patient with GBM suffered an intracerebral hematoma that was managed conservatively. Postoperative seizures were seen in 4 patients (3%), and 2 patients (1.5%) experienced a transient neurological deficit. Histological diagnosis showed a GBM in 64 cases, Grade III glioma in 19, Grade I or II in 23, metastasis in 10, lymphoma in 13, and other disease in 4. There were 32 patients discharged to home on the same day as surgery. Compared with the authors&#8217; previous retrospective audit into 127 biopsies, this technique showed improved diagnostic yield (99.3 vs 94.5%, p = 0.032) with fewer complications (2.2 vs 4.7% [not statistically significant]).</div>
<div style="text-align: justify;">Conclusions</div>
<div style="text-align: justify;">This technique of image-guided biopsy has high diagnostic yield with acceptably low morbidity and may be performed as a day case. Intraoperative neuropathological examination would not have increased the diagnostic yield further in this study, and its routine use may not be necessary. In the authors&#8217; department £70,350 (UK)/$114,522 (US) would have been saved by not using intraoperative neuropathology in this series. Therefore, intraoperative neuropathology should no longer be routinely recommended.</div>
</div>
<p><!-- /abstract content --></p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1459/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Absence of an association between glucose levels and surgical site infections in patients undergoing craniotomies for brain tumors</title>
		<link>http://www.neurosurgery-blog.com/archives/1454</link>
		<comments>http://www.neurosurgery-blog.com/archives/1454#comments</comments>
		<pubDate>Fri, 27 Aug 2010 04:00:19 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Infections]]></category>
		<category><![CDATA[complications]]></category>
		<category><![CDATA[craniotomy]]></category>
		<category><![CDATA[glucose]]></category>
		<category><![CDATA[hyperglycemia]]></category>
		<category><![CDATA[postoperative complication]]></category>
		<category><![CDATA[surgical site infection]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1454</guid>
		<description><![CDATA[J Neurosurg 113:161–166, 2010.DOI: 10.3171/2010.2.JNS09950
In select patient populations, hyperglycemia has been shown to increase the risk of surgical site infection (SSI), whereas stringent glucose control has improved outcomes. To date, no study has focused on whether SSIs in patients with brain tumors undergoing resection are associated with hyperglycemia. Methods. The authors performed a retrospective chart [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/08/Glucoselevels.jpg"><img class="alignleft size-medium wp-image-1455" title="Glucoselevels" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/08/Glucoselevels-300x222.jpg" alt="" width="115" height="85" /></a>J Neurosurg 113:161–166, 2010.DOI: 10.3171/2010.2.JNS09950</p>
<p style="text-align: justify;">In select patient populations, hyperglycemia has been shown to increase the risk of surgical site infection (SSI), whereas stringent glucose control has improved outcomes. To date, no study has focused on whether SSIs in patients with brain tumors undergoing resection are associated with hyperglycemia. Methods. The authors performed a retrospective chart review of patients who underwent a craniotomy after receiving a diagnosis of brain tumor. From 2001 to 2008, 2485 patients underwent a craniotomy for tumor resection at the Brain Tumor &amp; Neuro-Oncology Center at the Cleveland Clinic. Fifty-seven of these patients (2.3%) developed SSIs postoperatively. A matched case-control study design was used, with 57 patients who developed SSIs after craniotomy (cases) matched with 57 patients who did not develop SSIs (controls). The results were analyzed using both univariate and multivariate conditional logistic regression. Results. Glucose level was not a significant factor in postoperative SSI (p = 0.83) after adjusting for duration of surgery and adherence to antibiotic prophylaxis. However, duration of surgery was significantly associated with postoperative SSI (p = 0.047). Conclusions. For patients who undergo craniotomy for definitive resection of a brain tumor, duration of surgery described more variation in the model to predict SSI than blood glucose levels.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1454/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Endoscopic Third Ventriculostomy Vs Cerebrospinal Fluid Shunt in the Treatment of Hydrocephalus in Children: A Propensity Score–Adjusted Analysis</title>
		<link>http://www.neurosurgery-blog.com/archives/1448</link>
		<comments>http://www.neurosurgery-blog.com/archives/1448#comments</comments>
		<pubDate>Thu, 26 Aug 2010 04:00:16 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Endoscopy]]></category>
		<category><![CDATA[Outcome]]></category>
		<category><![CDATA[hydrocephalus]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Propensity score]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1448</guid>
		<description><![CDATA[Neurosurgery 67:588-593, 2010 DOI: 10.1227/01.NEU.0000373199.79462.21
Endoscopic third ventriculostomy (ETV) has preferentially been offered to patients with more favorable prognostic features compared with shunt.
OBJECTIVE: To use advanced statistical methods to adjust for treatment selection bias to determine whether ETV survival is superior to shunt survival once the bias of patientrelated prognostic factors is removed.
METHODS: An international cohort [...]]]></description>
			<content:encoded><![CDATA[<p>Neurosurgery 67:588-593, 2010 DOI: 10.1227/01.NEU.0000373199.79462.21</p>
<p style="text-align: justify;">Endoscopic third ventriculostomy (ETV) has preferentially been offered to patients with more favorable prognostic features compared with shunt.</p>
<p style="text-align: justify;">OBJECTIVE: To use advanced statistical methods to adjust for treatment selection bias to determine whether ETV survival is superior to shunt survival once the bias of patientrelated prognostic factors is removed.</p>
<p style="text-align: justify;">METHODS: An international cohort of children (≤ 19 years of age) with newly diagnosed hydrocephalus treated with ETV (n = 489) or shunt (n = 720) was analyzed. We used propensity score adjustment techniques to account for 2 important patient prognostic factors: age and cause of hydrocephalus. Cox regression survival analysis was performed to compare time-to-treatment failure in an unadjusted model and 3 propensity score—adjusted models, each of which would adjust for the imbalance in prognostic factors.</p>
<p style="text-align: justify;">RESULTS: In the unadjusted Cox model, the ETV failure rate was lower than the shunt failure rate from the immediate postoperative phase and became even more favorable with longer duration from surgery. Once patient prognostic factors were corrected for in the 3 adjusted models, however, the early failure rate for ETV was higher than that for shunt. It was only after about 3 months after surgery did the ETV failure rate become lower than the shunt failure rate.</p>
<p style="text-align: justify;">CONCLUSIONS: The relative risk of ETV failure is initially higher than that for shunt, but after about 3 months, the relative risk becomes progressively lower for ETV. Therefore, after the early high-risk period of ETV failure, a patient could experience a long-term treatment survival advantage compared with shunt. It might take several years, however, to realize this benefit.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1448/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
